Does Neoadjuvant Therapy Improve Outcome in Resectable PC? Gastrointestinal Cancers Symposium 2019.
- Published in:
- JOP Journal of the Pancreas, 2019, v. 20, n. 5, p. 155
- By:
- Publication type:
- Article
Works matching IS 15908577 AND DT 2019 AND VI 20 AND IP 5
Results: 6
1
2
Simplified/Same Day(s)-GOLF as First-line Treatment of Metastatic Carcinoma of Unknown Primary (CUP), Suggestive of Pancreatobiliary Tumors.
- Published in:
- JOP Journal of the Pancreas, 2019, v. 20, n. 5, p. 151
- By:
- Publication type:
- Article
3
Prognostic Factors in Patients with Pancreatic Adenocarcinoma and the Impact of Pancreatic Fistula on Oncologic Outcomes.
- Published in:
- JOP Journal of the Pancreas, 2019, v. 20, n. 5, p. 142
- By:
- Publication type:
- Article
4
A Comparative in vitro Assessment of Suture Strength after Exposure to Pancreatic Enzyme Solution.
- Published in:
- JOP Journal of the Pancreas, 2019, v. 20, n. 5, p. 138
- By:
- Publication type:
- Article
5
Pancreatic Exocrine Insufficiency after Total Gastrectomy - A Systematic Review.
- Published in:
- JOP Journal of the Pancreas, 2019, v. 20, n. 5, p. 130
- By:
- Publication type:
- Article
6
Pancreatic Enzyme Replacement Therapy: A Concise Review.
- Published in:
- JOP Journal of the Pancreas, 2019, v. 20, n. 5, p. 126
- By:
- Publication type:
- Article